Medical Equipment

Global Enzyme Immunoassay Industry Trends and Market Forecast 2026–2030

February 5, 2026February 5, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the workstation graphics processing unit (gpu) market from 2026–2035 with trusted insights from The Business Research Company

What level of growth is expected in the Enzyme Immunoassay Market between 2026 and 2030?

The enzyme immunoassay market size has experienced significant expansion in recent years. Forecasts indicate it will expand from $21.5 billion in 2025 to $23.09 billion in 2026, achieving a compound annual growth rate (CAGR) of 7.4%. Historically, this growth can be ascribed to several factors, including the limited availability of automated eia systems, reliance on manual microplate readers, the expansion of clinical laboratory infrastructure, the rising prevalence of chronic and infectious diseases, and the adoption of conventional reagents and kits.

The enzyme immunoassay market is projected to experience substantial expansion over the coming years, anticipated to reach $30.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 7.1%. Factors contributing to this growth during the forecast period include the advancement of fully automated EIA analyzers, the broadened scope of personalized medicine and precision diagnostics, the greater integration of laboratory information systems, the increasing uptake of software and data analysis tools, and the escalating demand from academic and research institutions. Key trends observed within the forecast period encompass the growing acceptance of automated EIA analyzers, an increase in therapeutic drug monitoring applications, the heightened utilization of multiplex testing and high-throughput assays, the broadening of oncology and infectious disease testing, and an intensified emphasis on laboratory data integration and workflow efficiency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25763&type=smp

Which Drivers Are Expected To Impact The Enzyme Immunoassay Market During The Forecast Period?

The increasing prevalence of infectious diseases is anticipated to boost the expansion of the enzyme immunoassay market. Infectious diseases are conditions caused by detrimental microorganisms like bacteria, viruses, fungi, or parasites, which can be transmitted between individuals. This burden is intensifying due to growing antimicrobial resistance, complicating the treatment of common infections and resulting in extended illnesses, elevated healthcare expenditures, and higher death rates. Enzyme immunoassays are crucial for diagnosing these diseases, offering sensitive and specific identification of antigens or antibodies in patient samples, which facilitates prompt detection, efficient tracking, and timely intervention for infections such as HIV, hepatitis, and influenza. As an illustration, the Minnesota Department of Health, a US-based government entity, reported in April 2025 that the proportion of HIV cases among males aged 35 to 39 climbed from 10% in 2023 to 17% in 2024, showing a significant rise in this demographic’s share of overall cases. Consequently, the rising burden of infectious diseases is propelling the growth of the enzyme immunoassay market.

Which Segments Are Driving Activity In The Enzyme Immunoassay Market?

The enzyme immunoassay market covered in this report is segmented –

1) By Product: Reagents And Kits, Analyzers Or Instruments, Software And Services

2) By Specimen: Blood, Saliva, Urine, Other Specimens

3) By Application: Therapeutic Drug Monitoring, Oncology, Cardiology, Endocrinology, Infectious Disease Testing, Autoimmune Diseases, Other Applications

4) By End-Use: Hospitals, Blood Banks, Clinical Laboratories, Pharmaceutical And Biotech Companies, Academic Research Centers, Other End-Uses

Subsegments:

1) By Reagents And Kits: Antibodies, Antigens, Substrates, Buffers And Stabilizers

2) By Analyzers Or Instruments: Fully Automated EIA Analyzers, Semi-Automated EIA Systems, Microplate Readers, Washers And Incubators

3) By Software And Services: Data Analysis And Interpretation Software, Laboratory Information System Integration Tools, Instrument Calibration And Validation Services, Technical Support And User Training

Which Market Trends Are Opening Growth Opportunities In The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are focusing on introducing innovative enzyme immunoassay (EIA) solutions, including fully automated enzyme immunoassays, with the goal of improving diagnostic accuracy, reducing manual errors, and enhancing workflow efficiency in clinical laboratories. Fully automated enzyme immunoassays represent diagnostic systems that perform the entire testing process automatically, thereby improving speed, accuracy, and consistency in laboratory results. For example, in July 2024, Fujirebio Holdings Inc., a Japan-based in vitro diagnostics (IVD) company, released the fully automated Lumipulse G GFAP assay for research use only (RUO), which expanded its neuro-biomarker portfolio. This particular RUO chemiluminescent enzyme immunoassay quantifies glial fibrillary acidic protein (GFAP) in human plasma and serum using the LUMIPULSE G platform, providing results in just 35 minutes. It functions as an astrocytic biomarker implicated in conditions such as multiple sclerosis, Alzheimer’s and Parkinson’s diseases, stroke, and traumatic brain injury. This assay further enhances Fujirebio’s expanding neuro menu, which already includes NfL, pTau217, and sTREM2, supporting comprehensive neurodegenerative disease profiling on a single automated system.

Which Key Market Players Are Investing In Expansion And Innovation Within The Enzyme Immunoassay Market?

Major companies operating in the enzyme immunoassay market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories Inc., Danaher Corporation, Merck KGaA, Siemens Healthineers AG, Becton Dickinson and Company (BD), PerkinElmer Inc., BioMérieux SA, Bio-Rad Laboratories Inc., Diasorin S.p.A., Bio-Techne Corporation, Quidel Corporation, Promega Corporation, Abcam plc, BioLegend Inc., Helena Laboratories Corporation, Cayman Chemical Company, Enzo Life Sciences Inc., RayBiotech Inc., MyBioSource Inc., Boster Biological Technology, Hycult Biotech, Calbiotech Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/enzyme-immunoassay-global-market-report

Which Region Is Expected To Experience The Fastest Growth In The Enzyme Immunoassay Market?

North America was the largest region in the enzyme immunoassay market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the enzyme immunoassay market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Enzyme Immunoassay Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25763&type=smp

Browse Through More Reports Similar to the Global Enzyme Immunoassay Market 2026, By The Business Research Company

Enteral Feeding Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-devices-global-market-report

Enteral Feeding Formula Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-feeding-formula-global-market-report

Enteral Nutrition Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/enteral-nutrition-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795